WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2000026239) $I(CHLAMYDIA) ANTIGENS AND CORRESPONDING DNA FRAGMENTS AND USES THEREOF
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2000/026239    International Application No.:    PCT/GB1999/003622
Publication Date: 11.05.2000 International Filing Date: 02.11.1999
Chapter 2 Demand Filed:    05.05.2000    
IPC:
A61K 39/00 (2006.01), C07K 14/295 (2006.01)
Applicants: CONNAUGHT LABORATORIES LIMITED [CA/CA]; 1755 Steeles Avenue West Toronto, Ontario M2R 3T4 (CA) (For All Designated States Except US).
MURDIN, Andrew, David [GB/CA]; (CA) (For US Only).
OOMEN, Raymond, Peter [CA/CA]; (CA) (For US Only).
DUNN, Pamela, Lesley [GB/CA]; (CA) (For US Only)
Inventors: MURDIN, Andrew, David; (CA).
OOMEN, Raymond, Peter; (CA).
DUNN, Pamela, Lesley; (CA)
Agent: SCHLICH, George, William; Mathys & Squire 100 Gray's Inn Road London WC1X 8AL (GB)
Priority Data:
60/106,590 02.11.1998 US
60/133,071 07.05.1999 US
09/430,723 29.10.1999 US
Title (EN) $I(CHLAMYDIA) ANTIGENS AND CORRESPONDING DNA FRAGMENTS AND USES THEREOF
(FR) ANTIGENES DE CHLAMYDIA ET FRAGMENTS D'ADN CORRESPONDANTS ET LEURS UTILISATIONS
Abstract: front page image
(EN)In summary of this disclosure, the present invention provides a method of nucleic acid, including DNA, immunization of a host, including humans, against disease caused by infection by a strain of Chlamydia, specifically $I(C. pneumoniae), employing a vector, containing a nucleotide sequence encoding an POMP91B precursor protein of a strain of $I(Chlamydia pneumoniae) and a promoter to effect expression of the POMP91B precursor gene in the host. Modifications are possible within the scope of this invention.
(FR)L'invention concerne un procédé d'immunisation d'un hôte, basé sur des acides nucléiques, y compris ADN, concernant également des hôtes humains, contre des maladies provoquées par l'infection par une souche de Chlamydia, en particulier, C. pneumoniae, mettant en application un vecteur, contenant une séquence de nucléotides codant un protéine de précurseur de POMP91B d'une souche de Chlamydia pneumoniae et un promoteur servant à effectuer l'expression du précurseur de POMP91B chez l'hôte. L'invention peut également englober des modifications.
Designated States: AE, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, CA, CH, CN, CR, CU, CZ, DE, DK, DM, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)